Indications
Treatment of multiple sclerosis
Composition
- Active substance
- laquinimod
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Nerventra
- Active substance
- laquinimod
- ATC code
- N07
- Group
- Nervous system
- Therapeutic area
- Multiple Sclerosis
- Marketing authorisation holder
- Teva Pharma GmbH
- Status
- Refused
- Refused
- 19 Aug 2014
- EMA product number
- EMEA/H/C/002546